Literature DB >> 21039417

Nrf2-mediated liver protection by sauchinone, an antioxidant lignan, from acetaminophen toxicity through the PKCδ-GSK3β pathway.

Hee Yeon Kay1, Young Woo Kim, Da Hye Ryu, Sang Hyun Sung, Se Jin Hwang, Sang Geon Kim.   

Abstract

BACKGROUND AND PURPOSE Sauchinone, an antioxidant lignan, protects hepatocytes from iron-induced toxicity. This study investigated the protective effects of sauchinone against acetaminophen (APAP)-induced toxicity in the liver and the role of nuclear factor erythroid-2-related factor-2 (Nrf2) in this effect. EXPERIMENTAL APPROACH Blood biochemistry and histopathology were assessed in mice treated with APAP or APAP + sauchinone. The levels of mRNA and protein were measured using real-time PCR assays and immunoblottings. KEY RESULTS Sauchinone ameliorated liver injury caused by a high dose of APAP. This effect was prevented by a deficiency of Nrf2. Sauchinone treatment induced modifier subunit of glutamate-cysteine ligase, NAD(P)H:quinone oxidoreductase-1 (NQO1) and heat shock protein 32 in the liver, which was abolished by Nrf2 deficiency. In a hepatocyte model, sauchinone activated Nrf2, as evidenced by the increased nuclear accumulation of Nrf2, the induction of NQO1-antioxidant response element reporter gene, and glutamate-cysteine ligase and NQO1 protein induction, which contributed to the restoration of hepatic glutathione content. Consistently, treatment of sauchinone enhanced Nrf2 phosphorylation with a reciprocal decrease in its interaction with Kelch-like ECH-associated protein-1. Intriguingly, sauchinone activated protein kinase C-δ (PKCδ), which led to Nrf2 phosphorylation. In addition, it increased the inhibitory phosphorylation of glycogen synthase kinase-3β (GSK3β), derepressing Nrf2 activity, which was supported by the reversal of sauchinone's activation of Nrf2 by an activated mutant of GSK3β. Moreover, phosphorylation of GSK3β by sauchinone depended on PKCδ activation. CONCLUSION AND IMPLICATIONS Our results demonstrate that sauchinone protects the liver from APAP-induced toxicity by activating Nrf2, and this effect is mediated by PKCδ activation, which induces inhibitory phosphorylation of GSK3β.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21039417      PMCID: PMC3166693          DOI: 10.1111/j.1476-5381.2010.01095.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  35 in total

Review 1.  Protein oxidation and aging.

Authors:  E R Stadtman
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

2.  The role of phase II antioxidant enzymes in protecting memory T cells from spontaneous apoptosis in young and old mice.

Authors:  Hyon-Jeen Kim; Andre E Nel
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

3.  Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene.

Authors:  Hye-Youn Cho; Anne E Jedlicka; Sekhar P M Reddy; Liu-Yi Zhang; Thomas W Kensler; Steven R Kleeberger
Journal:  Am J Respir Cell Mol Biol       Date:  2002-01       Impact factor: 6.914

4.  Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity.

Authors:  Hiromi Okawa; Hozumi Motohashi; Akira Kobayashi; Hiroyuki Aburatani; Thomas W Kensler; Masayuki Yamamoto
Journal:  Biochem Biophys Res Commun       Date:  2005-11-08       Impact factor: 3.575

Review 5.  Selective protein arylation and acetaminophen-induced hepatotoxicity.

Authors:  S D Cohen; E A Khairallah
Journal:  Drug Metab Rev       Date:  1997 Feb-May       Impact factor: 4.518

6.  Novel small molecule inhibitors of 3-phosphoinositide-dependent kinase-1.

Authors:  Richard I Feldman; James M Wu; Mark A Polokoff; Monica J Kochanny; Harald Dinter; Daguang Zhu; Sandra L Biroc; Bruno Alicke; Judi Bryant; Shendong Yuan; Brad O Buckman; Dao Lentz; Mike Ferrer; Marc Whitlow; Marc Adler; Silke Finster; Zheng Chang; Damian O Arnaiz
Journal:  J Biol Chem       Date:  2005-03-16       Impact factor: 5.157

7.  Acetaminophen toxicity. Opposite effects of two forms of glutathione peroxidase.

Authors:  O Mirochnitchenko; M Weisbrot-Lefkowitz; K Reuhl; L Chen; C Yang; M Inouye
Journal:  J Biol Chem       Date:  1999-04-09       Impact factor: 5.157

8.  The effect of omeprazole pretreatment on acetaminophen metabolism in rapid and slow metabolizers of S-mephenytoin.

Authors:  T Sarich; T Kalhorn; S Magee; F al-Sayegh; S Adams; J Slattery; J Goldstein; S Nelson; J Wright
Journal:  Clin Pharmacol Ther       Date:  1997-07       Impact factor: 6.875

9.  An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements.

Authors:  K Itoh; T Chiba; S Takahashi; T Ishii; K Igarashi; Y Katoh; T Oyake; N Hayashi; K Satoh; I Hatayama; M Yamamoto; Y Nabeshima
Journal:  Biochem Biophys Res Commun       Date:  1997-07-18       Impact factor: 3.575

10.  Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription.

Authors:  H-C Huang; Truyen Nguyen; Cecil B Pickett
Journal:  J Biol Chem       Date:  2002-08-26       Impact factor: 5.157

View more
  16 in total

1.  The role of natural products in revealing NRF2 function.

Authors:  Donna D Zhang; Eli Chapman
Journal:  Nat Prod Rep       Date:  2020-05-13       Impact factor: 13.423

2.  Nuclear factor (erythroid-derived 2)-like 2, the brake in oxidative stress that nicotinamide adenine dinucleotide phosphate-oxidase-4 needs to protect the heart.

Authors:  Thalita B Abrahao; Kathy K Griendling
Journal:  Hypertension       Date:  2014-12-22       Impact factor: 10.190

3.  Therapeutic targeting of GSK3β enhances the Nrf2 antioxidant response and confers hepatic cytoprotection in hepatitis C.

Authors:  Yongfang Jiang; Hui Bao; Yan Ge; Wei Tang; Du Cheng; Kaizhong Luo; Guozhong Gong; Rujun Gong
Journal:  Gut       Date:  2014-05-08       Impact factor: 23.059

4.  Targeting Glycogen Synthase Kinase-3β for Therapeutic Benefit against Oxidative Stress in Alzheimer's Disease: Involvement of the Nrf2-ARE Pathway.

Authors:  Katja Kanninen; Anthony R White; Jari Koistinaho; Tarja Malm
Journal:  Int J Alzheimers Dis       Date:  2011-05-02

5.  Protection against acetaminophen-induced acute liver failure by omentum adipose tissue derived stem cells through the mediation of Nrf2 and cytochrome P450 expression.

Authors:  Yu-Jen Huang; Poda Chen; Chih-Yuan Lee; Sin-Yu Yang; Ming-Tsan Lin; Hsuan-Shu Lee; Yao-Ming Wu
Journal:  J Biomed Sci       Date:  2016-01-19       Impact factor: 8.410

6.  Nrf2 inhibits epithelial-mesenchymal transition by suppressing snail expression during pulmonary fibrosis.

Authors:  Wencheng Zhou; Xiaoting Mo; Wenhui Cui; Zhihui Zhang; Delin Li; Liucheng Li; Liang Xu; Hongwei Yao; Jian Gao
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

7.  Sake lees hydrolysate protects against acetaminophen-induced hepatotoxicity via activation of the Nrf2 antioxidant pathway.

Authors:  Kayoko Kawakami; Chie Moritani; Misugi Uraji; Akiko Fujita; Koji Kawakami; Tadashi Hatanaka; Etsuko Suzaki; Seiji Tsuboi
Journal:  J Clin Biochem Nutr       Date:  2017-09-05       Impact factor: 3.114

Review 8.  Role of the Nrf2-ARE pathway in liver diseases.

Authors:  Sang Mi Shin; Ji Hye Yang; Sung Hwan Ki
Journal:  Oxid Med Cell Longev       Date:  2013-05-09       Impact factor: 6.543

Review 9.  The Role of Oxidative Stress and Antioxidants in Liver Diseases.

Authors:  Sha Li; Hor-Yue Tan; Ning Wang; Zhang-Jin Zhang; Lixing Lao; Chi-Woon Wong; Yibin Feng
Journal:  Int J Mol Sci       Date:  2015-11-02       Impact factor: 5.923

Review 10.  Chronic over-nutrition and dysregulation of GSK3 in diseases.

Authors:  Xunxian Liu; Zemin Yao
Journal:  Nutr Metab (Lond)       Date:  2016-08-04       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.